These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4727440)

  • 1. Inactivation of complement (C3) in human serum by atopic allergens.
    Berrens L; van Rijswijk-Verbeek J
    Int Arch Allergy Appl Immunol; 1973; 45(1):30-9. PubMed ID: 4727440
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhalant allergens in human atopic disease: their chemistry and modes of action.
    Berrens L
    Ann N Y Acad Sci; 1974; 221():183-98. PubMed ID: 4132119
    [No Abstract]   [Full Text] [Related]  

  • 3. Characteristics of complement consumption by atopic allergens.
    Berrens L; Van Rijswijk-Verbeek J; Guikers CL
    Immunochemistry; 1976 May; 13(5):367-72. PubMed ID: 939579
    [No Abstract]   [Full Text] [Related]  

  • 4. [Inactivation of the house dust allergen by UV-irradiation].
    Bruchhausen D; Geissler G; Haschem J
    Z Immunitatsforsch Allerg Klin Immunol; 1969 Nov; 138(5):434-8. PubMed ID: 4244396
    [No Abstract]   [Full Text] [Related]  

  • 5. C3 and C5-cleaving properdin enzymes formed on zymosan incubated with human serum: the decay and the regeneration of the enzymes.
    Fujita T; Takiuchi M; Matsumoto M; Nagaki K; Inai S
    Int Arch Allergy Appl Immunol; 1977; 53(4):303-9. PubMed ID: 67089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and biological properties of some atopic allergens.
    King TP
    Adv Immunol; 1976; 23():77-105. PubMed ID: 793359
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of complement-derived enzymes.
    Fearon DT; Austen KF
    Ann N Y Acad Sci; 1975 Jun; 256():441-50. PubMed ID: 808993
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoproteomic characterization of Ambrosia artemisiifolia pollen allergens in canine atopic dermatitis.
    Ognjenovic J; Milcic-Matic N; Smiljanic K; Vuckovic O; Burazer L; Popovic N; Stanic-Vucinic D; Velickovic TC
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):38-47. PubMed ID: 23830203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1683-7. PubMed ID: 266208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of zymosan and of activated properdin with factor D-depleted guinea pig serum: implications for the mechanism of initial C3 cleavage via the alternative complement pathway.
    Brade V; Bentley C; Bitter-Suermann D; Hadding U
    Z Immunitatsforsch Immunobiol; 1977 Feb; 152(5):402-14. PubMed ID: 556571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergen diagnosis of the atopic symptom complex].
    Chlebarov S; Menger W
    Monatsschr Kinderheilkd (1902); 1973 Jun; 121(6):235-6. PubMed ID: 4737376
    [No Abstract]   [Full Text] [Related]  

  • 12. Value of fluid phase complement consumption as a means of 'in vitro' allergen standardization.
    Berrens L; Guikers CL
    Dev Biol Stand; 1975; 29():235-48. PubMed ID: 1171039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGE AND SEX IN ATOPIC AND NON-ATOPIC VASOMOTOR RHINITIS (OUT-PATIENTS' VISITS AND ATOPIZATION TO HOUSE-DUST AND POLLEN).
    VAREKAMP H; VOORHORST R
    Acta Allergol; 1964; 19():500-14. PubMed ID: 14233636
    [No Abstract]   [Full Text] [Related]  

  • 14. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphocyte transformation test (LTT) applied to children with atopic asthma caused by allergens in house dust.
    Olivé A; García-Calderón JV; Vich JM; García-Calderón PA
    Ann Allergy; 1978 Aug; 41(2):116-20. PubMed ID: 686501
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of reaginic activity with IgA serum fractions from patients sensitive to grass pollens and house dust.
    Radermecker M
    Pathol Eur; 1969; 4(1):1-11. PubMed ID: 4180838
    [No Abstract]   [Full Text] [Related]  

  • 17. Alternative pathway of complement: demonstration and characterization of initiating factor and its properdin-independent function.
    Schreiber RD; Götze O; Müller-Eberhard HJ
    J Exp Med; 1976 Oct; 144(4):1062-75. PubMed ID: 62010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of skin prick tests and evaluation of serum antigen specific immunoglobulin E in patients with atopic dermatitis and airborne allergy with regards to the type of sensitising allergens and seasonal course of the disease].
    Silny P; Czarnecka-Operacz M; Silny W
    Pol Merkur Lekarski; 2005 Apr; 18(106):393-9. PubMed ID: 16161918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity to phenylglycine acid chloride.
    Kammermeyer JK; Mathews KP
    J Allergy Clin Immunol; 1973 Aug; 52(2):73-84. PubMed ID: 4124984
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.